Limited Period Offer:Be a PRO for 1 month @Rs49/-Multiple payment options available. Know More
you are here: HomeNewsTrendsHealth

Take strict action against those indulged in black marketing, hoarding of Remdesivir: Centre to states

Chemicals and Fertilisers Minister D V Sadananda Gowda said he has also taken a meeting with the pharma secretary to review the availability of the antiviral drug which is used in the treatment of COVID-19.

April 19, 2021 / 08:01 PM IST

State governments have been asked to take strict action against anyone found indulged in black marketing or hoarding of antiviral drug remdesivir, Chemicals and Fertilisers Minister D V Sadananda Gowda said on Monday.

The minister said he has also taken a meeting with the pharma secretary to review the availability of the antiviral drug which is used in the treatment of COVID-19.

"Took a meeting with the Secretary (Pharma) to review availability of #Remdesivir. Government is in regular touch with manufacturers regarding this. Weekly production plans have been prepared in consultation with the manufacturers," Gowda tweeted.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

Black marketing, hoarding of remdesivir is being strictly monitored and state governments have been advised to take strict action against those indulging in such malpractices, he added.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

In another tweet, the minister said: "Manufacturers have agreed to ramp up production of #Remdesivir. Additional sites for production have been approved. Production to be doubled in coming weeks."

On Sunday, Minister of State of Chemicals and Fertilisers Mansukh L Mandaviya had tweeted that the government plans to double the production of remdesivir to around 3 lakh vials per day over the next 15 days, to make it available readily for the treatment of COVID-19.

The government has given permission to 20 plants to produce the antiviral drug, he had said.

Already, remdesivir is being rolled out of 20 plants in the country.

On Saturday, the National Pharmaceutical Pricing Authority (NPPA) had announced that the pharmaceutical companies like Cadila Healthcare, Dr Reddy's Laboratories and Cipla have reduced the price of their respective brands of remdesivir injection (100mg/vial).

Follow our full coverage of the coronavirus pandemic here.
first published: Apr 19, 2021 08:01 pm

stay updated

Get Daily News on your Browser